BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laryngoscope
,
Lovastatin
,
rs7903146
,
ZBTB7A
,
Coagulation
,
Arthritis
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
AHNAK2;jsessionid=1DA5313FDEF7B46A2324A36D709D5B6D
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dorsal root ganglia
Nipple cross-section
Skin
Oral mucosa
Trigeminal ganglia
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hyperglycemia
Preterm premature rupture of membranes
Injury of integument
Duchenne muscular dystrophy
Peritoneal foreign body
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
stachydrine chloride
5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid
saikosaponin
salvianolic acid B
astragaloside IV
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
TRAF3
KCNK1
FGFR4
Pik3ca
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway.
AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway.
Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway.
AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid can…
AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for AHNAK2;jsessionid=1DA5313FDEF7B46A2324A36D709D5B6D
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ